Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2018 Feb 6;70(3):327–332. doi: 10.1002/acr.23295

Table 2.

Linear regression model estimates of difference in DAS28-CRP3 compared to eating fish never to <1/month

Frequency of fish consumption

Never to <1/month
n=35
1/month to <1/week
n=72
1/week
n=38
≥2/week
n=31
Difference in DAS28-CRP3 per 1 additional serving of fish/week+
Model adjusted for:* β-coefficient (95% confidence interval) β-coefficient (95% CI)
Age and sex 0 (ref) −0.32 (−0.73, 0.10) −0.32 (−0.79, 0.15) −0.65 (−1.15, −0.15) −0.22 (−0.40, −0.04)
Age, sex, body mass index, depression, married 0 (ref) −0.23 (−0.62, 0.16) −0.36 (−0.81, 0.08) −0.49 (−0.97, −0.02) −0.18 (−0.35, −0.004)
Age, sex, body mass index, depression, married, bDMARD, fish oil 0 (ref) −0.24 (−0.64, 0.15) −0.39 (−0.85, 0.06) −0.51 (−0.99, −0.02) −0.18 (−0.35, −0.003)
*

All models are adjusted for total energy intake. Covariates: age in decades, sex, body mass index in kg/m2 (<25, 25 to <30, ≥30), CES-Depression score (continuous), married (yes/no), biologic DMARD use (yes/no), fish oil supplement use (yes/no)

+

β-coefficient (95% CI) from linear regression models including a term representing the median frequency of fish consumption per week in each exposure group